Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Comment by ArimaForecaston May 02, 2020 12:23pm
285 Views
Post# 30979428

RE:Aphria will C R U $ H this Q and I mean O B L I T E R A T E

RE:Aphria will C R U $ H this Q and I mean O B L I T E R A T E
Altman Z-score is good, accurate, but it did not consider the opportunity factors, unforeseen events, brand notoriety.
Apha dominates the German market and possibly Europe. The score can go up with future partner, future entry to the American market, changes in local policies, continuation of positive results, the recession gives more anti-depressant consumption ....
An investor is one who assesses opportunistic factors. Less risk, less reward, and vice versa, that's the rule.
Altman Z-score helps alert the firm to further improve in the future
Anyway, being a data scientist, I'm curious to know how Sentieo firm ranks ACB at 1.14
<< Previous
Bullboard Posts
Next >>